当前位置: 首页 > 详情页

Genetically confirmed familial hypercholesterolemia due to a novel mutation in the low density lipoprotein receptor gene leading to familial hhypercholesterolemia in hypercholesterolemic outpatients with hypercholesterolemia

| 认领 | 导出 |

文献详情

资源类型:

收录情况: ◇ CSCD-C

机构: [a]Emergency and Critical Care Center, Beijing Anzhen Hospital, Capital Medical University, Beijing, China [b]Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, Beijing, China [c]Beijing Anzhen Hospital, Affiliated to Capital Medical University, Department of Dermatology, Beijing, China [d]Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China [e]Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, 2 Anzhen Street, Chaoyang District, Beijing, 100029, China [f]Beijing Anzhen Hospital, Capital Medical Univ., Beijing Institute of Heart Lung and Blood Vessel Disease, Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, 2 Anzhen Street, Chaoyang District, Beijing, 100029, China
出处:
ISSN:

关键词: Familial hypercholesterolemia Low-density lipoprotein receptorLDL receptor Mutation

摘要:
Bbackground Familial hypercholesterolemia (FH) is, an autosomal dominant disorder of lipoprotein metabolism which can lead to premature coronary heart disease (pCHD)., is mainly caused by mutations in the low-density lipoprotein receptor (LDLR) gene. according to the Dutch Lipid Clinic Network criteria. There are about 3.8 million potential FH patients in China, whereas the clinical and genetic data of FH are limited. In this study, genetic screening and functional analyses were conducted in 65 Chinese clinical definite FH patients in order to better understand FH pathogenicity and the mechanism by which certain genetic mutations result in FH. Methods Dutch Lipid Clinic Network(DLCN) criteria was used to diagnose definite FH in the hypercholesterolemic outpatients with hypercholesterolemia. Resequencing chip analysis combined with Sanger sequencing validation were used to identify mutations in the five6 these clinical definite FH patients according to Dutch Lipid Clinic NetworkDLCN criteria according to the Dutch Lipid Clinic Network criteria. In silico analysis was conducted in mutations with unknown pathogeniciwith typreviously unknown pathogenicity. Then, the novel mutant receptors were transfected into human embryo kidney 293(HEK-293) cells. The binding and the internalization activities of the mutant receptorLDLRs novel mutation receptors were analyzed by flow cytometry. The prevalence of definite FH in hypercholesterolemia outpatients with hypercholesterolemiain in this study is 1.953.20%. Using genetic testing, oOne homozygous FH (HoFH), one heterozygous FH (HeFH) and 3 compound heterozygous FH patients were confirmed. 8 Eight mutations in Low-density lipoprotein receptor(the LDLR) gene were identified, in which c.357delG was a novel mutation and cosegregated with the FH phenotype. BFamily verification and bioinformatic analysis confirmed that c.357delG as was a pathogenic mutation. Furthermore, when compared with the wild-type LDLRs by flow cytometry analysis, the binding and internalization activities of c.357delG mutant LDLRs were reduced by 35% and 49%, respectively. Thus, the c.357delG mutation was likely the molecular mechanism underlying the etiology of FH in this family. Conclusions This study identified eight LDLR gene mutations in six five patients with clinicaldefinite definite Chinese FH probandspatients, in which c.357delG is a novel pathogenic mutation. These findings increase our understanding of the genetic spectrumbackground of FH in the Chinese populationa. © 2018 Science Press. All rights reserved.

基金:
语种:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 4 区 医学
小类 | 4 区 心脏和心血管系统 4 区 老年医学
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 心脏和心血管系统 4 区 老年医学
第一作者:
第一作者机构: [a]Emergency and Critical Care Center, Beijing Anzhen Hospital, Capital Medical University, Beijing, China [b]Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, Beijing, China [c]Beijing Anzhen Hospital, Affiliated to Capital Medical University, Department of Dermatology, Beijing, China [d]Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China [e]Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, 2 Anzhen Street, Chaoyang District, Beijing, 100029, China [f]Beijing Anzhen Hospital, Capital Medical Univ., Beijing Institute of Heart Lung and Blood Vessel Disease, Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, 2 Anzhen Street, Chaoyang District, Beijing, 100029, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院